Steven L. Hoerter
Officer, Clovis Oncology.
Companies
- MBX Biosciences, Inc.Chief executive officer Aug 4, 2026 to now1
- MBX Biosciences, Inc.President Aug 4, 2026 to now1
- Yarrow Bioscience, Inc.Board member Jul 29, 2026 to now2
- MBX Biosciences, Inc.Board member Apr 7, 2025 to now3
- C4 Therapeutics (United States)Board member Nov 21, 2024 to now4
- Oric Pharmaceuticals, Inc.Board member Aug 16, 2021 to now5
- Deciphera Pharmaceuticals, Inc.Chief executive officer Mar 20, 2019 to Jun 11, 20246
- Deciphera Pharmaceuticals, Inc.President Mar 20, 2019 to Jun 11, 20246
- Deciphera Pharmaceuticals, Inc.Board member May 21, 2018 to Jun 11, 20247
- Constellation Pharmaceuticals (United States)Board member Sep 5, 2018 to Jul 23, 20218
- Agios PharmaceuticalsChief Commercial Officer Feb 18, 2016 to Mar 5, 20199
- Clovis OncologyOfficer Nov 15, 2011 to Mar 9, 201510
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- MBX Biosciences, Inc. MBX102,938 shares11$5.4M at $52.51Aug 4, 2026
- Deciphera Pharmaceuticals, Inc.0 shares12Jun 11, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 3, 2026Granted 71,000 shares of MBX Biosciences, Inc.11
- May 1, 2026Granted 11,938 shares of MBX Biosciences, Inc.13
- Oct 17, 2025Bought 20,000 shares at $13.25 of MBX Biosciences, Inc.14
- Jun 11, 2024U 72,763 shares of Deciphera Pharmaceuticals, Inc.12
- Jun 11, 2024Returned to company 286,075 shares of Deciphera Pharmaceuticals, Inc.12
- Jun 11, 2024Granted 286,075 shares of Deciphera Pharmaceuticals, Inc.12
- Dec 13, 2023Sold 30,664 shares at $15.37 of Deciphera Pharmaceuticals, Inc.15
- Dec 12, 2023Granted 62,500 shares of Deciphera Pharmaceuticals, Inc.15
- Oct 30, 2023Sold 21,573 shares at $12.02 of Deciphera Pharmaceuticals, Inc.16
- Oct 28, 2023Granted 62,500 shares of Deciphera Pharmaceuticals, Inc.16
- Mar 21, 2023Sold 7,500 shares at $15.57 of Deciphera Pharmaceuticals, Inc.17
- Feb 14, 2023Sold 30,045 shares at $16.00 of Deciphera Pharmaceuticals, Inc.18
- Mar 21, 2022Shares withheld for tax 3,150 shares at $9.11 of Deciphera Pharmaceuticals, Inc.19
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARMBX Biosciences, Inc., Board member
- 4
- 5
- 6
- 7
- 8
- 9
- 10SEC EDGARClovis Oncology, Officer
- 11
- 12
- 13SEC EDGARForm 4 filed May 4, 2026
- 14SEC EDGARForm 4 filed Oct 20, 2025
- 15SEC EDGARForm 4 filed Dec 14, 2023
- 16SEC EDGARForm 4 filed Oct 31, 2023
- 17SEC EDGARForm 4 filed Mar 23, 2023
- 18SEC EDGARForm 4 filed Feb 16, 2023
- 19SEC EDGARForm 4 filed Mar 23, 2022